Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Indira Guleria"'
Autor:
Mary E. Keir, Arlene H. Sharpe, Subbulaxmi Trikudanathan, Mohamed H. Sayegh, Bechara Mfarrej, Shirine Dada, Indira Guleria
Publikováno v:
Clinical Immunology. 140:47-53
Anti-CD3 mAb is an effective therapy that can reverse diabetes in NOD mice and has therapeutic potential in patients with type 1 diabetes (T1D). We administered anti-CD3 to PDL1-/-.NOD mice in order to determine whether this treatment would reverse t
Autor:
Mohammed Javeed I. Ansari, Paolo Fiorina, Nidyanandh Vadivel, Shirine Dada, Brian T. Fife, Qizhi Tang, Hideo Yagita, Miyuki Azuma, Mark A. Atkinson, Subbulaxmi Trikudanathan, Indira Guleria, Melanie Gubbels Bupp, Jeffrey A. Bluestone, Mohamed H. Sayegh
Publikováno v:
Clinical Immunology. 125:16-25
The PD-1-PDL1 pathway plays a critical role in regulating autoimmune diabetes as blockade or deficiency of PD-1 or PDL1 results in accelerated disease in NOD mice. We explored the cellular mechanisms involved in the regulation of these autoimmune res
Autor:
Nidyanandh Vadivel, Miyuki Azuma, Hideo Yagita, Melanie Gubbels Bupp, Shirine Dada, Jingxiong She, Mohammed Javeed I. Ansari, Arezou Khosroshahi, Jeffrey A. Bluestone, Sarah Eckenrode, Paolo Fiorina, Subbulaxmi Trikudanathan, Mohamed H. Sayegh, Mark A. Atkinson, Indira Guleria
Publikováno v:
Clinical Immunology. 119:S168